Indee is developing simple hardware for scalable engineered cell therapy.
Location: Australia, New South Wales, Berkeley
Employees: 11-50
Total raised: $5.9M
Founded date: 2015
Investors 5
| Date | Name | Website |
| - | BioTools I... | biotoolsin... |
| 23.04.2023 | BroadOak C... | broadoak.c... |
| - | Y Combinat... | ycombinato... |
| - | MBC BioLab... | mbcbiolabs... |
| - | Main Seque... | mseq.vc/ |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.02.2019 | Grant | $500K | - |
| 18.05.2018 | Seed | $5.4M | Main Seque... |
Mentions in press and media 15
| Date | Title | Description |
| 31.03.2026 | Becker Transactions Announces Global Patent Portfolio Defining Future of Engineered Cell Therapy Manufacturing | STARKVILLE, MS, UNITED STATES, March 31, 2026 /EINPresswire.com/ -- Indee Labs, a company pioneering microfluidic technologies for intracellular delivery, today announced the availability of its commercial-ready patented Hydropore™ platform... |
| 15.05.2023 | Indee Labs Adopts Scispot to Operate as a Digital Biotech Company | Scispot, the creator of the best tech stack for modern biotech, announces its partnership with Indee Labs, the developer of Hydropore for non-viral intracellular delivery. This collaboration aims to empower Indee Labs to digitalize and cent... |
| 11.05.2023 | Indee Labs Adopts Scispot to Operate as a Digital Biotech Company | Scispot Not only does Scispot perfect our internal technical operations, but the seamless integration and automation capabilities offered by Scispot make it a lot easier to operate as a distributed biotech company. KITCHENER, ON (PRWEB) May... |
| 22.09.2020 | Indee Labs Awarded Contract from the National Cancer Institute | Indee Labs announces a contract award from the National Cancer Institute to develop the µVS Delivery SystemTM for modified T cell immunotherapy manufacturing BERKELEY, Calif.–(BUSINESS WIRE)–September 22, 2020– Indee Labs is a biotechnology... |
| 24.08.2020 | Indee Labs Awarded Grant from the National Institute of Allergy and Infectious Diseases | Indee Labs announces a grant award from the National Institute of Allergy and Infectious Diseases to develop the µVS Delivery SystemTM for modified regulatory T cells BERKELEY, Calif.–(BUSINESS WIRE)–August 24, 2020– Indee Labs is a biotech... |
| 12.12.2019 | Indee Labs Issued United States and International Patents for Intracellular Delivery System | Indee Labs announces issuance of patents in the United States, Canada, Japan and Australia for intracellular delivery with a system for microfluidic vortex shedding BERKELEY, Calif.–(BUSINESS WIRE)–December 12, 2019– Indee Labs, a biotechno... |
| 22.05.2019 | Indee Labs Announces Formation of Strategic Advisory Board | Indee Labs Strategic Advisory Board Includes Six Globally-Recognised Experts in the Discovery, Development and Commercialisation of Microfluidic Devices and Cell Therapies like Chimeric Antigen Receptor T-cells (CAR-T) BERKELEY, Calif. &... |
| 08.08.2018 | NSW Health Funds Indee Labs’ First Preclinical Study Into Gene-Modified Cell Therapy Manufacturing for Blood Cancer | This preclinical study will pave the way for biopharmaceutical companies to transition away from using viruses. The aim is to enable gene-modified cell therapy manufacturing with open source biology to provide patients with improved access ... |
| 21.05.2018 | Term Sheet — Monday, May 21 | FORTUNE 500 DAY Good morning, Term Sheet readers. Paid Content How can you protect what you can't see? From ExtraHop The top 5 include Walmart, Exxon Mobil, Berkshire Hathaway, Apple, and UnitedHealth Group. Here are some takeaways from thi... |
| 18.05.2018 | Indee Labs Closes $5.4M in Seed Funding | SAN FRANCISCO, CA, Indee Labs received $2.6M in venture financing extending its seed-stage funding to more than $5.4M. >> Click here for more funding data on Indee Labs >> To export Indee Labs funding data to PDF and Excel, ... |
Show more